Vous êtes sur la page 1sur 3

cliexa Acquires Preventative Technology Solutions Inc.

cliexa® has acquired Colorado-based Preventative Technology Solutions Inc. and will incorporate
their digital health solutions for adolescent resiliency into cliexa's existing platform for chronic care
management.

Denver, CO, October 25, 2018 --(PR.com)-- cliexa, Inc., developer of a mobile software platform for
chronic disease management, announces their decision today to acquire Preventative Technology
Solutions Inc. (PTSI), a provider of medical assessment applications and mHealth prevention services for
adolescents and young adults. Preventative Technology Solutions was a winner of the Prime Health
Challenge in 2016.

cliexa had previously licensed PTSI's assessment technology to launch cliexa-OPTIONS, a suite of
behavioral health apps for primary care instantly identifying risk level for sexual activity, substance use
and other issues for adolescents. cliexa-OPTIONS is perfect for primary care and specialty clinics that
need to screen adolescents for depression, suicide risk, anxiety sexual risk, and substance abuse. Major
health systems, including UC Health Longmont are leveraging the risk screening assessments in its clinic.

The product, cliexa-OPTIONS, delivers precise, evidence-based assessments that patients complete on a
tablet in the physician's office before their appointment, creating a structured report using proprietary
algorithms for each risk area. The reproductive health app supports early identification of patients at
highest risk of acquiring an STD or experiencing an unplanned pregnancy. All the screening apps identify
both risk and resiliency in adolescents.

With this acquisition, cliexa will build on its innovative healthcare technology solutions to foster a
platform that is designed to educate and assess a technologically-literate generation of adolescents on the
importance of understanding their behavioral health and allow physicians to identify and monitor at-risk
individuals easily. This leads to more in-depth conversations between patients and their physicians which
is a significant step necessary to reduce costs and chronic conditions often associated with adolescent
behavioral health.

“I know that the power of the cliexa platform maximizes patient-reported outcomes,” says Co-Founder of
PTSI, Lisa Rue, Ph.D., who has joined the cliexa team in a new role as a Senior Advisor and Policy
Advisor. “Our clients love the user-friendly interface, structured, intelligent reports and mobile health
technology. We envision improved access for primary care physicians, public and private clinics saving
time, improving reimbursement, and reducing long-term negative health outcomes by partnering with the
cliexa-OPTIONS platforms.”

Mehmet Kazgan, Co-Founder and CEO of cliexa, says, “Our partnership with Preventative Technology
Solutions Inc was a great milestone in 2017 while expanding cliexa's capabilities with adolescents sexual
risk prediction and monitoring features. With this acquisition, cliexa adds unique values to its variety of
clinical assessment and monitoring platforms for exclusive resiliency screening model which is very
crucial for pediatrics and primary care services.”

Page 1/3
PR.com Press Release Distribution Terms of Use
About cliexa

The mobile platform technology developed by cliexa enables patients to track their chronic disease
activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models.
cliexa delivers quantified disease activity and medication adherence through patient-reported outcomes
through real-time integration to electronic medical records, which streamline processes and increase
efficiency in population health management.

Learn more about cliexa at www.cliexa.com

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
cliexa
Jeffrey Mutchnik
847-767-9719
Contact via Email
www.cliexa.com

Online Version of Press Release:


You can read the online version of this press release at: https://www.pr.com/press-release/768313

News Image:

Page 3/3
PR.com Press Release Distribution Terms of Use

Vous aimerez peut-être aussi